Insights

Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.

Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, and senior counsel Allie Shalom, co-chair of the firm’s Payor/Provider Convergence Area of Focus, are speaking in Healthcare Financial Management Association’s upcoming webinar titled “Private Equity and Health Care – A Policy Discussion” on April 30.

Foley is proud to continue its sponsorship of the American Telemedicine Association (ATA) to offer a plethora of industry insights with attendees during ATA Nexus 2025, exploring The Next Chapter in Virtual Care.  

In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent owners to include expanded categories of domestic investment to satisfy the economic prong of the domestic industry requirement under Section 337(a)(3)(B).

A recent federal court decision marks an important win for automotive suppliers in the ongoing debate over what constitutes a valid requirements contract under Michigan law following the Michigan Supreme Court’s decision in MSSN, Inc. v. Airboss Flexible Products Co. (2023).

There was much hope going into 2025 that we would see a rebound in the IPO market after a bit of a drought over the past few years. We left the uncertainty of the election behind us, and good news on the inflation and interest rate fronts were fueling a sense of hope that 2025 was going to be a great year for the IPO market.

This episode of The Path & The Practice features a conversation with William McKenna. Bill is a litigation partner in Foley’s Chicago office.

This episode of The Path & The Practice features a conversation with Andrew Wronski. Andy is a litigation partner in Foley’s Milwaukee office where he is also the office managing partner.

This episode of The Path & The Practice features a conversation with special guest Akshay Verma. Akshay is COO at Spotdraft.

Since 2018, licensing deals totaling over $60 billion have been signed regarding Antibody Drug Conjugates (ADCs), with 2023 alone having at least 18 deals.

As we make further strides into 2024, the fashion, apparel & beauty landscape continues its dynamic evolution, marked by opportunities and challenges.

Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.

The SEC now permits public marketing of private placements, without burdensome investor wealth verification requirements, if the investment is big enough.

On March 13, 2025, several amendments to the Amparo Law were published. These amendments intend to harmonize the Amparo Law with the recent modifications made to the structure and operation of the Federal Judicial System.

Foley & Lardner LLP (Foley) and Relativity began experimenting with GPT products in 2023, which evolved into the “aiR” suite of GPT-based tools currently available today. Foley’s participation and success with early experiments encouraged Foley legal teams to push novel uses of aiR to see how it would perform.